IL6 and Insulin resistance: Further, inflammatory mediators associated with periodontitis increase the risk of insulin resistance, causing dysglycemia [7,8], while periodontal therapy can improve insulin resistance by reducing circulating inflammatory mediators, such as C-reactive protein, tumor necrosis factor, interleukin-6, and fibrinogen, in patients with type 2 diabetes [9].